This study is in progress, not accepting new patients
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedcompletion around
- Principal Investigator
- by Joseph Califano (ucsd)
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Joseph Califano (ucsd)
Professor, Surgery, Vc-health Sciences-schools. Authored (or co-authored) 405 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Diego
- ID
- NCT03993353
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 7 people participating
- Last Updated